Individualized regimen of low-dose rituximab monotherapy for new-onset AChR-positive generalized myasthenia gravis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Individualized regimen of low-dose rituximab monotherapy for new-onset AChR-positive generalized myasthenia gravis

Published:2022-03-03 Issue:8 Volume:269 Page:4229-4240
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Du Ying,Li Chuan,Hao Yun-feng,Zhao Chao,Yan Qi,Yao Dan,Li Lin,Zhang Wei^ORCID

Funder

National Natural Science Foundation of China

Key project of research and development plan of Shaanxi Province

Key project of basic natural science research program of Shaanxi Province

Tangdu hospital innovation development foundation

Tangdu hospital clinical research project

Tangdu hospital foundation for social recruitment talent

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-022-11048-4.pdf

Reference33 articles.

1. Gilhus NE (2016) Myasthenia gravis. N Engl J Med 375(26):2570–2581. https://doi.org/10.1056/NEJMra1602678

2. Morren J, Li Y (2020) Maintenance immunosuppression in myasthenia gravis, an update. J Neurol Sci 410:116648. https://doi.org/10.1016/j.jns.2019.116648

3. Rath J, Brunner I, Tomschik M et al (2020) Frequency and clinical features of treatment-refractory myasthenia gravis. J Neurol 267(4):1004–1011. https://doi.org/10.1007/s00415-019-09667-5

4. Mantegazza R, Antozzi C (2020) From traditional to targeted immunotherapy in myasthenia gravis: prospects for research. Front Neurol 11:981. https://doi.org/10.3389/fneur.2020.00981

5. Farmakidis C, Pasnoor M, Dimachkie MM et al (2018) Treatment of myasthenia gravis. Neurol Clin 36(2):311–337. https://doi.org/10.1016/j.ncl.2018.01.011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Few-shot adaptation of multi-modal foundation models: a survey;Artificial Intelligence Review;2024-08-27

2. Low-dose rituximab regimen does not increase severe COVID-19 risk in patients with neuroimmune diseases during the pandemic: a cross-sectional study;2024-07-29

3. Advancements and prospects of novel biologicals for myasthenia gravis: toward personalized treatment based on autoantibody specificities;Frontiers in Pharmacology;2024-05-27

4. Treating myasthenia gravis beyond the eye clinic;Eye;2024-05-24

5. Defending Language Models Against Image-Based Prompt Attacks via User-Provided Specifications;2024 IEEE Security and Privacy Workshops (SPW);2024-05-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3